Home › Squamous Cell Carcinoma ng Ulo at Leeg › California › Santa Monica

Pag-aaral pangklinika para sa Squamous Cell Carcinoma ng Ulo at Leeg sa Santa Monica, CA

Isang pag-aaral para sa Squamous Cell Carcinoma ng Ulo at Leeg ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Santa Monica. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors

Nagre-recruitPhase 1

Santa Monica UCLA Medical Center & Orthopaedic Hospital, Santa Monica
UCLA Hematology/Oncology - Santa Monica, Santa Monica

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 1, 2026 · NCT07090499

A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors

Nagre-recruitPhase 1

ALX Center 11, Santa Monica

Edad 18 pataas · Lahat ng kasarian · Na-update Set 30, 2026 · NCT07085091

A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation

Nagre-recruitPhase 1

Research Site, Santa Monica

Edad 18 pataas · Lahat ng kasarian · Na-update Set 29, 2026 · NCT05877599

BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study

Nagre-recruitPhase 2

Tower Cancer Research Foundation, Beverly Hills · 6 mi ang layo

Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT05136196

Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis

Nagre-recruitPhase 1/2

Precision NextGen Oncology, Beverly Hills · 6 mi ang layo

Edad 18 pataas · Lahat ng kasarian · Na-update Set 24, 2026 · NCT06047379

A Study of KIVU-107 in Participants With Locally Advanced or Metastatic Solid Tumors

Nagre-recruitPhase 1

Kivu Trial Site, Santa Monica

Edad 18 pataas · Lahat ng kasarian · Na-update Set 24, 2026 · NCT07229313

Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors

Nagre-recruitPhase 1

UCLA Santa Monica, Santa Monica
Beverly Hills Cancer Center, Beverly Hills · 6 mi ang layo

Edad 18 pataas · Lahat ng kasarian · Na-update Set 21, 2026 · NCT05983432

Comparing Radiation Plus Cetuximab to Radiation Plus Chemotherapy in People With Head and Neck Cancer Who Cannot Receive Cisplatin

Nagre-recruitPhase 3

Tower Cancer Research Foundation, Beverly Hills · 6 mi ang layo

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 17, 2026 · NCT07441681

A Study of Sigvotatug Vedotin in Advanced Solid Tumors

Nagre-recruitPhase 1

UCLA Department of Medicine - Hematology & Oncology, Santa Monica

Edad 18 pataas · Lahat ng kasarian · Na-update Hul 6, 2026 · NCT04389632

A Phase 1, First-in-human Study of OKN4395 and Pembrolizumab in Patients With Solid Tumors

Nagre-recruitPhase 1

Sarcoma Oncology Center, Santa Monica
Precision NextGen Oncology and Research Center, Beverly Hills · 6 mi ang layo

Edad 18 pataas · Lahat ng kasarian · Na-update Hun 11, 2026 · NCT06789172

A Study of DB-1310 in Advanced/Metastatic Solid Tumors

Nagre-recruitPhase 1/2

UCLA Hematology/Oncology - Santa Monica, Santa Monica

Edad 18 pataas · Lahat ng kasarian · Na-update Abr 6, 2026 · NCT05785741

A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors

Nagre-recruitPhase 1/2

Research Site 128, Santa Monica

Edad 18 pataas · Lahat ng kasarian · Na-update Nob 21, 2025 · NCT05914116

A Beta-only IL-2 ImmunoTherapY Study

Nagre-recruitPhase 1/2

Providence Saint John's Health Center, Santa Monica

Edad 18 pataas · Lahat ng kasarian · Na-update Hul 9, 2025 · NCT05086692

Pag-aaral para sa Squamous Cell Carcinoma ng Ulo at Leeg sa ibang lungsod

Iba pang pag-aaral sa Santa Monica

Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.